447 related articles for article (PubMed ID: 125289)
21. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
Khan F; Siddiqui AA
Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
[TBL] [Abstract][Full Text] [Related]
22. Complement-fixing material in ther sera of patients with rheumatoid arthritis.
McDuffie FC; Hunder GG; Clark RJ
Clin Exp Immunol; 1978 May; 32(2):218-25. PubMed ID: 668197
[TBL] [Abstract][Full Text] [Related]
23. Rheumatoid factors bind beta 2 microglobulin. Detection of beta 2 microglobulin-complexes in rheumatoid arthritis.
Falus A; Merétey K; Böhm U; Bozsóky S
Arch Immunol Ther Exp (Warsz); 1979; 27(5):647-54. PubMed ID: 94990
[TBL] [Abstract][Full Text] [Related]
24. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.
Cheema GS; Roschke V; Hilbert DM; Stohl W
Arthritis Rheum; 2001 Jun; 44(6):1313-9. PubMed ID: 11407690
[TBL] [Abstract][Full Text] [Related]
25. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
[TBL] [Abstract][Full Text] [Related]
26. [The clinical significance of synovial fluid examination].
Yu MX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Aug; 11(4):274-7. PubMed ID: 2532973
[TBL] [Abstract][Full Text] [Related]
27. [Circulating immune complexes and anti-IgG antibodies in rheumatoid arthritis].
Duquesnoy B; Santoro F; Wattre P; Delcambre B
Rev Rhum Mal Osteoartic; 1978 Jun; 45(6):417-21. PubMed ID: 308254
[TBL] [Abstract][Full Text] [Related]
28. A study of complement fixation by rheumatoid factor using a haemolytic assay system.
Taylor-Upsahl MM; Johnson PM; Mellbye OJ; Natvig JB
Clin Exp Immunol; 1977 May; 28(2):204-11. PubMed ID: 872448
[TBL] [Abstract][Full Text] [Related]
29. Immune complexes and complement in rheumatoid arthritis.
Lambert PH; Casali P; Nydegger U
Bull Schweiz Akad Med Wiss; 1979 Sep; 35(4-6):301-15. PubMed ID: 534786
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series.
Wager O; Lindström P; Räsänen JA; Kekomäki R; Ziola B; Salmi A; Isomäki H; Skrifvars B; Penttinen K
Clin Exp Immunol; 1981 Oct; 46(1):149-60. PubMed ID: 7337967
[TBL] [Abstract][Full Text] [Related]
31. A monoclonal anti-idiotype specific for human polyclonal IgM rheumatoid factor.
Davidson A; Lopez J; Sun D; Prus D
J Immunol; 1992 Jun; 148(12):3873-8. PubMed ID: 1376343
[TBL] [Abstract][Full Text] [Related]
32. Circulating immune complexes and rheumatoid arthritis: the induction of immune complex formation between rheumatoid factor and IgG by polyethylene glycol.
Faaber P; van den Bersselaar LA; van de Putte L; van den Berg WB
J Rheumatol; 1989 Oct; 16(10):1304-9. PubMed ID: 2681758
[TBL] [Abstract][Full Text] [Related]
33. Anti-xanthine oxidase antibodies in sera and synovial fluid of patients with rheumatoid arthritis and other joint inflammations.
Arrar L; Hanachi N; Rouba K; Charef N; Khennouf S; Baghiani A
Saudi Med J; 2008 Jun; 29(6):803-7. PubMed ID: 18521455
[TBL] [Abstract][Full Text] [Related]
34. Anti-MBL autoantibodies in patients with rheumatoid arthritis: prevalence and clinical significance.
Gupta B; Raghav SK; Agrawal C; Chaturvedi VP; Das RH; Das HR
J Autoimmun; 2006 Sep; 27(2):125-33. PubMed ID: 16904869
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.
Naama JK; Mitchell WS; Whaley K
Clin Exp Immunol; 1983 Nov; 54(2):429-38. PubMed ID: 6652966
[TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of circulating immune complexes in patients with rheumatoid arthritis.
Perego R; Vezzoli S; Manfredi W; Bigi G; Procaccia S
Boll Ist Sieroter Milan; 1983 Nov; 62(5):462-8. PubMed ID: 6608359
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of Clq binding activity by IgM rheumatoid factor.
Zilberfarb JL; Andrews BS; Young AC; Davis JS
J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433
[TBL] [Abstract][Full Text] [Related]
38. Immune complexes in rheumatoid arthritis sera and synovial fluids: a comparison of three methods.
Halla JT; Volanakis JE; Schrohenloher RE
Arthritis Rheum; 1979 May; 22(5):440-8. PubMed ID: 444313
[TBL] [Abstract][Full Text] [Related]
39. [Inhibition of expontaneous cytotoxicity and antibody dependency by rheumatoid synovial fluid].
Noguera Hernando E; Kreisler M; Durantez A; Larrea Gayarre A; de Landazuri MO; Cruz Martínez J
Allergol Immunopathol (Madr); 1978; 6(3):253-62. PubMed ID: 717203
[TBL] [Abstract][Full Text] [Related]
40. Molecular analysis of complement-fixing rheumatoid synovial fluid immune complexes.
Male DK; Roitt IM
Clin Exp Immunol; 1981 Dec; 46(3):521-9. PubMed ID: 7337979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
